Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1996-10-24
|
pubmed:abstractText |
The optimum regimen for the treatment of cryptococcal meningitis in patients with AIDS is still not totally clear. The triazoles fluconazole and itraconazole are associated with response rates of 50%-60%. Amphotericin B appears to be associated with a more rapid clearance of organisms, and there are some data suggesting that initial therapy with amphotericin B is preferable to that with triazoles; however, this finding has not been definitively shown in large comparative trials. Results of a recently completed large trial suggested that initial treatment with amphotericin B followed by triazole therapy is associated with an acute mortality rate (approximately 6%) that is substantially less than that in previous studies. Relapse is common (20%-60% of cases) if the patient does not receive chronic suppressive therapy. The drug of choice for maintenance therapy is fluconazole (200 mg/d). A recent trial showed that fluconazole was superior to itraconazole (200 mg/d) as suppressive therapy. Prophylactic use of fluconazole (200 mg/d) significantly decreases the incidence of cryptococcosis and mucosal candidiasis, especially in patients with CD4 cell counts of < 50/mm3. However, because of the lack of a survival benefit and the risk of the selection effect on fluconazole-resistant Candida, it is difficult to make the recommendation of routine prophylaxis with fluconazole for all patients with AIDS; the decision to use prophylaxis should be based on more selective criteria.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1058-4838
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22 Suppl 2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S119-23
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8722838-AIDS-Related Opportunistic Infections,
pubmed-meshheading:8722838-Amphotericin B,
pubmed-meshheading:8722838-Antifungal Agents,
pubmed-meshheading:8722838-Clinical Trials as Topic,
pubmed-meshheading:8722838-Combined Modality Therapy,
pubmed-meshheading:8722838-Fluconazole,
pubmed-meshheading:8722838-Humans,
pubmed-meshheading:8722838-Intracranial Pressure,
pubmed-meshheading:8722838-Itraconazole,
pubmed-meshheading:8722838-Meningitis, Cryptococcal
|
pubmed:year |
1996
|
pubmed:articleTitle |
Recent advances in the management of cryptococcal meningitis in patients with AIDS.
|
pubmed:affiliation |
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review
|